RCM
INFI

Rotella Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Rotella Capital Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,300
Closed -$174K – 630
2014
Q4 		$174K Buy
+10,300
New +$150K 0.15% 168

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rotella Capital Management's INFI Position: Q1 2015 in Review

Rotella Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2015, closing a stake of 10,300 shares — an estimated $174K sold.

Rotella Capital Management first reported a position in INFI in Q4 2014 and held it in 1 quarter. The position peaked at $174K in Q4 2014. 141 funds tracked by Wall St. Rank hold INFI as of Q1 2015.

  • Rotella Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Rotella Capital Management sold 10,300 Infinity Pharmaceuticals, Inc. shares in Q1 2015, an estimated $174K.
  • Rotella Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2014 and held it in 1 quarter.
  • Rotella Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $174K in Q4 2014.
  • 141 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2015.

Based on Rotella Capital Management's 13F filing for Q1 2015, filed 4 May 2015.